Drupal.behaviors.print = function(context) {window.print();window.close();}>
TrovaGene Licenses SF3B1 Mutations, Plans LDT
January 03, 2012
TrovaGene Licenses SF3B1 Mutations, Plans LDT
Full-text access for registered users only.
Existing users
login here
.
New to GenomeWeb?
Register here
quickly for free access.
Related Stories
TrovaGene Licenses Leukemia Assay Technology
September 7, 2011 / GenomeWeb Daily News
Trovagene, PerkinElmer Ink Assay Development Deal Targeting Liver Cancer
April 26, 2013 / GenomeWeb Daily News
Novartis' Genoptix Licenses Trovagene Marker for AML Services
December 20, 2012 / GenomeWeb Daily News
Trovagene Licenses Leukemia Marker to Quest Diagnostics
September 13, 2012 / GenomeWeb Daily News
Proteome Sciences Inks Stroke Biomarker Licensing Deal with Randox
April 5, 2012 / GenomeWeb Daily News